-

CONTINUED INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Stanley Black & Decker Inc.’s Directors and Officers for Breach of Fiduciary Duties – SWK

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, continues its investigation whether certain directors and officers of Stanley Black & Decker, Inc. (“Stanley Black & Decker”) (NYSE: SWK) breached their fiduciary duties to Stanley Black & Decker and its shareholders. If you are a Stanley Black & Decker shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether members of Stanley Black & Decker’s board of directors or senior management failed to manage it in an acceptable manner, in breach of their fiduciary duties to Stanley Black & Decker, and whether Stanley Black & Decker and its shareholders have suffered damages as a result.

On February 23, 2023, Stanley Black & Decker identified transactions among its international operations that may have violated the U.S. Foreign Corrupt Practices Act, according to a filing with the U.S. Securities Exchange Commission.

What You Can Do

If you are a Stanley Black & Decker shareholder, you may have legal claims against their directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982, or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NYSE:SWK

Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300
San Diego, CA 92101
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Hub Group, Inc. (NASDAQ: HUBG)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Hub Group is a transport...

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor Ltd., Zhenyang Shi, Li Xu, Cogency Global, Joseph Stone Capital, LLC, and Marcum Asia CPAs, LLP (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern District of New York and captioned Louie v. PomDoctor Ltd. et al., Ca...

ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Eli Lilly and Company (“Eli Lilly”) (NYSE: LLY) breached their fiduciary duties to Eli Lilly and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Eli Lilly’s board of directors or senior management failed to manage Eli Lilly in an acceptable manner, in breach of their fid...
Back to Newsroom